Literature DB >> 11527863

The performance of social marketing in reaching the poor and vulnerable in AIDS control programmes.

N Price1.   

Abstract

The article reviews evidence on the impact and effectiveness of condom social marketing programmes (CSMPs) in reaching the poor and vulnerable with information, services and products in the context of HIV/AIDS/STD prevention and control. Ideally, the success of CSMPs would be judged by whether they contribute to sustained improvements in sexual health outcomes at the population level. Given methodological and attribution difficulties, intermediary criteria are employed to assess effectiveness and impact, focusing on changes in behaviour (including condom use) among poor and vulnerable groups, and access by the poor and vulnerable to condoms, services and information. It remains difficult to reach definitive conclusions about the extent to which CSMPs meet the sexual health needs of the poor and vulnerable, due largely to reliance on sales data for CSMP monitoring and evaluation. CSMPs (like many health programme strategies) have traditionally collected little information on client profiles, health-seeking behaviour, condom use effectiveness, and supply-side issues. Recent data indicate that CSMPs are unlikely to be pro-poor in their early stages, in terms of the distribution of benefits, but as CSMPs mature, then inequities in access diminish, followed by reduced inequities in condom use. The paper assesses the extent to which social marketing is effective in improving access for the poor and vulnerable using a number of variables. In terms of economic access, it is evident that low-income groups are particularly sensitive to CSMP price increases, and that a cost-recovery focus excludes the poorest. Convenience is significantly improved for those who can afford to pay, and CSMPs appear to be addressing social and regulatory constraints to access. Conventional CSMP monitoring systems make it difficult to assess the effectiveness of behavioural change IEC strategies, although data on this dimension of the social marketing approach are beginning to emerge.

Entities:  

Mesh:

Year:  2001        PMID: 11527863     DOI: 10.1093/heapol/16.3.231

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  7 in total

Review 1.  Effects of condom social marketing on condom use in developing countries: a systematic review and meta-analysis, 1990-2010.

Authors:  Michael D Sweat; Julie Denison; Caitlin Kennedy; Virginia Tedrow; Kevin O'Reilly
Journal:  Bull World Health Organ       Date:  2012-05-29       Impact factor: 9.408

2.  Multilevel social influences on female condom use and adoption among women in the urban United States.

Authors:  Margaret R Weeks; Helena Hilario; Jianghong Li; Emil Coman; Maryann Abbott; Laurie Sylla; Michelle Corbett; Julia Dickson-Gomez
Journal:  AIDS Patient Care STDS       Date:  2010-05       Impact factor: 5.078

3.  A marketing perspective on disseminating evidence-based approaches to disease prevention and health promotion.

Authors:  Edward W Maibach; Mary Ann S Van Duyn; Bonny Bloodgood
Journal:  Prev Chronic Dis       Date:  2006-06-15       Impact factor: 2.830

4.  Health care coverage among long-distance truckers in India: an evaluation based on the Tanahashi model.

Authors:  Varun Sharma; Niranjan Saggurti; Shalini Bharat
Journal:  HIV AIDS (Auckl)       Date:  2015-03-23

5.  Injecting drug users and their health seeking behavior: a cross-sectional study in dhaka, bangladesh.

Authors:  Sheikh Mohammed Shariful Islam; Tuhin Biswas; Faiz Ahmed Bhuiyan; Md Serajul Islam; Mohammad Mizanur Rahman; Hurun Nessa
Journal:  J Addict       Date:  2015-01-27

Review 6.  Leveraging the lessons learned from financing HIV programs to advance the universal health coverage (UHC) agenda in the East African Community.

Authors:  Henry Zakumumpa; Sara Bennett; Freddie Ssengooba
Journal:  Glob Health Res Policy       Date:  2019-09-13

7.  Malaria control in Malawi: are the poor being served?

Authors:  Don P Mathanga; Cameron Bowie
Journal:  Int J Equity Health       Date:  2007-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.